Ancrod
medication Under reviewAncrod is a purified polypeptide derived from Malayan pit viper venom that acts as a defibrinogenating agent. It cleaves fibrinogen, lowering circulating fibrinogen levels and altering clot formation, which gives it anticoagulant-like effects. It was investigated mainly as a treatment for thrombotic and ischemic conditions, especially acute ischemic stroke. Because its primary action is on the coagulation system, ancrod is not a general wellness supplement and is best understood as an experimental or historical drug-like compound rather than a mainstream dietary supplement.
Research summary
In healthy humans, there are no meaningful supplementation studies because ancrod has been studied primarily as an injectable therapeutic in patients with acute ischemic stroke, not as a routine supplement for healthy adults. The available human evidence therefore does not support general health use in healthy people. Mechanistic and clinical literature show that ancrod reduces fibrinogen and can promote fibrin formation, which helps explain why it was explored for clot-related disease and why bleeding risk is a major concern. The overall research consensus is that ancrod is an experimental anticoagulant agent with limited clinical adoption and no established healthy-person benefits.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Ancrod to your stack to report effects
Intravenous Ancrod for Treatment of Acute Ischemic Stroke: The STAT Study
The STAT Investigators
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Coronary artery disease or other cardiac conditions
Intravenous Ancrod for Treatment of Acute Ischemic Stroke: The STAT Study
The STAT Investigators
Research (1 study)
Intravenous Ancrod for Treatment of Acute Ischemic Stroke: The STAT Study
The STAT Investigators
Community updates
No updates yet for this supplement.
Be the first to share your experience!